OP0189 GENETICS OF JUVENILE IDIOPATHIC ARTHRITIS: THE IDENTIFICATION OF A NOVEL RISK LOCUS AND CLINICAL SUBGROUP ANALYSIS

Background Juvenile idiopathic arthritis (JIA) is a clinically heterogeneous group of childhood onset inflammatory joint diseases with strong evidence to support a genetic contribution to susceptibility. JIA is divided into seven clinical subgroups based on observed patterns of clinical symptoms using the International League of Associations for Rheumatology (ILAR) classification system. The genetic overlap between these groups is not completely understood and this lack of knowledge typically leads to the different ILAR groups being analysed as discrete entities and reducing the overall power of genetic association studies. Objectives The aim of this study was to conduct a large case-control association study on susceptibility to JIA to identify novel susceptibility loci and to investigate differences of these associations between the ILAR groups. Methods JIA participants were genotyped on the Illumina Infinium CoreExome or OmniExpress arrays at The University of Manchester. UK population control genotype data was obtained from the Understanding Society Longitudinal Study. Quality control of data was performed conforming to conventional standards based on call rate, cryptic relatedness and ancestry outliers. Imputation was performed using the Haplotype Reference Consortium panel on the Michigan Imputation Server followed by exclusion of SNPs with low imputation accuracy (r2 Results Following quality control the dataset consisted of > 7.4 million SNPs for 3305 JIA cases and 9196 controls. Association testing in a combined dataset of all ILAR groups identified seven SNPs associated at genome-wide significance (5x10-8); six of these have previously been reported for JIA while one is a novel association. The novel association (rs497523, p-value = 7.12x10-9, OR 0.85, 95% CI 0.8:0.9) maps to chromosome 16p11 and is located within intron one of the CCDC101 gene. In a subset of 44 independently associated SNPs we found no strong evidence to support association of any SNP to a specific ILAR group with the majority of the SNPs showing evidence for sharing across multiple groups. Conclusion In the largest case control association study for susceptibility to JIA performed to date, we identified a novel association to a SNP in the intron of CCDC101. This gene is involved in transcriptional regulation through histone acetyltransferase. CCDC101 may be the causal gene at this locus; however introns contain enhancer elements that regulate other genes in the transcriptional domain. Therefore fine mapping with the integration of genomic data is currently being performed for this locus. The results provide little evidence to support ILAR subgroup specificity for any of the associated variants; on the contrary the results support a general model of sharing across multiple groups. The combined analysis of data across subgroups, informed by model sharing, will maximise power to identify novel associations. Disclosure of Interests None declared